Browse by category

Ascletis Pharma has completed enrolment in its 13-week US Phase II study evaluating ASC30, an oral small molecule GLP-1 receptor (GLP-1R) agonist, for the treatment of type 2 diabetes mellitus (T2D). T2D is the second indication for ASC30, following its first indication of obesity. Topline data from the Phase II study for the treatment of T2D are expected in the third quarter of 2026. The Phase II study is a 13-week, randomised, double-blind, placebo-controlled and multi-cent

A prospective randomised controlled pilot study by researchers from Mansoura University, Mansoura, Egypt, has demonstrated that concomitant laparoscopic cholecystectomy (LC) during bariatric surgery in patients with morbidly obesity with pre-existing gallstones is safe and feasible. Although concomitant LC results in longer operative time (mean increase of 23.75 min) and higher immediate postoperative pain scores, the researchers noted that these differences do not translate

Johnson & Johnson has received European CE Mark approval for its new ETHICON 4000 Stapler, an advanced surgical stapler designed to deliver reliable staple line integrity across a wide range of tissue thickness. ETHICON 4000 Stapler With proprietary 3D Stapling Technology, a redesigned end-effector and streamlined reload options, the ETHICON 4000 and ETHICON 3D Reloads are certified for use in open and laparoscopic surgery across the European Union. The new advanced stapling

Compliance with any multivitamin and/or protein supplement regimen can be difficult, especially after bariatric surgery. Nutritional deficiency, as a result of gastric bypass surgery, is a substantial possibility without any form of supplementation and even with compliance to standard multivitamin supplementation.1 Problematic adherence The multivitamin supplementation (MVS) regimen could have a major impact on patient adherence,

Women who lost weight using GLP-1 medications are judged more harshly than those who lost weight through diet and exercise, with negative reactions driven largely by beliefs that medication-assisted weight loss is a ‘shortcut’, according to a study by Georgetown University Medical Center researchers. The study also found higher levels of stigma when the women in sample scenarios were portrayed as white rather than Black. The findings highlight how social narratives about ‘acc

In this exclusive interview, Professor Luis Ocaña (Hospital Universitario Virgen de la Victoria de Málaga, Spain), IFSO-EC Malaga 2026 Congress President, discusses some of the key highlights at this year’s meeting with a particular focus on the Pre-Congress Courses, the importance medication and surgery, collaboration with SECO (Spanish Society of Bariatric Surgery) and, of course, the sights and sounds of the beautiful city of Malaga... “We have been working with huge enthu